Core Viewpoint - President Trump warns pregnant women to avoid Tylenol, citing a potential link between acetaminophen and autism, despite a lack of widely accepted scientific evidence supporting this claim [1] Group 1: Government Actions and Statements - The U.S. government plans to modify drug safety labels and launch a nationwide public health campaign regarding acetaminophen use during pregnancy [1] - The FDA has stated that it has not found clear evidence that appropriate use of acetaminophen during pregnancy leads to adverse pregnancy, birth, or developmental outcomes [4][6] Group 2: Scientific Community's Response - Various professional organizations, including the American College of Obstetricians and Gynecologists, argue against discouraging the use of acetaminophen due to its benefits, especially since it is often the only recommended antipyretic for pregnant women [4] - A large-scale study published in 2024 found no increased risk of autism in children whose mothers used acetaminophen during pregnancy [3] Group 3: Legal Context - Prior to Trump's warning, numerous lawsuits claimed that exposure to Tylenol during pregnancy led to autism in children, but a judge dismissed these claims, citing flawed scientific evidence [5] - The legal debate continues, with appeals expected later this year in Manhattan, and the Department of Health and Human Services' statements may influence the court's considerations [5][6]
宣称“对乙酰氨基酚可能导致自闭症”,特朗普警告孕妇避免服用泰诺
Hua Er Jie Jian Wen·2025-09-23 00:41